
Macular degeneration is an eye condition that affects the macula, the part of the retina responsible for sharp central vision. This can make everyday tasks like reading, recognizing faces, driving, or seeing fine details more difficult over time.
For many patients in Flagstaff, one of the biggest questions is whether macular degeneration can be slowed or stabilized. While macular degeneration cannot always be reversed, early diagnosis, careful monitoring, and the right treatment plan can help protect vision and support long-term eye health.
There are two main types of age-related macular degeneration, often called AMD. Dry AMD is the more common form and typically develops gradually as retinal tissue changes and drusen deposits build up. Wet AMD is less common but can progress more quickly because of abnormal blood vessel growth beneath the retina.
At Eye Care Associates, we evaluate macular degeneration with a personalized approach so patients in Flagstaff can better understand their diagnosis, risk factors, and options for care.
In many cases, the goal of macular degeneration care is to slow progression, stabilize vision, and detect changes as early as possible. Regular eye exams and retinal imaging are important because AMD can progress before noticeable vision loss occurs.
Depending on the type and stage of AMD, care may include lifestyle guidance, nutritional support, retinal monitoring, referrals when needed, and advanced treatment options. The earlier changes are detected, the more opportunity there may be to protect remaining vision.
Eye Care Associates is proud to be the only practice in Flagstaff offering Photobiomodulation (PBM) Therapy for dry age-related macular degeneration. PBM is a non-invasive, drug-free light therapy that uses specific wavelengths of red, yellow, and near-infrared light to support retinal cell activity.
Each PBM therapy session takes only about 8 minutes and is designed to help stimulate cellular function in the retina. For some patients with dry AMD, PBM may help slow progression, stabilize vision, or support visual improvement when used as part of a personalized treatment plan.
PBM therapy is most often considered for patients with early to intermediate dry AMD. A comprehensive retinal evaluation helps determine whether this option is appropriate based on your eye health, visual symptoms, and stage of macular degeneration.
PBM therapy may be recommended for patients who:
Some patients remain stable for long periods, while others experience more noticeable changes. Routine monitoring allows our team to track retinal health, identify progression, and adjust recommendations when needed. For patients in Flagstaff, having access to PBM therapy at Eye Care Associates gives us another tool to support dry AMD care beyond observation alone.
Contact Eye Care Associates to schedule a macular degeneration consultation or learn more about PBM therapy for dry AMD. Visit our office in Flagstaff, Arizona, or call (928) 774-7949 to book an appointment today.